Select Medical Holdings Co. (NYSE:SEM) Shares Purchased by KBC Group NV

KBC Group NV boosted its position in shares of Select Medical Holdings Co. (NYSE:SEM) by 4.5% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 13,050 shares of the health services provider’s stock after acquiring an additional 563 shares during the quarter. KBC Group NV’s holdings in Select Medical were worth $455,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in Select Medical by 5.3% during the first quarter. Vanguard Group Inc. now owns 12,997,891 shares of the health services provider’s stock valued at $391,886,000 after purchasing an additional 650,093 shares during the period. Point72 Asset Management L.P. boosted its stake in shares of Select Medical by 179.5% in the second quarter. Point72 Asset Management L.P. now owns 843,528 shares of the health services provider’s stock worth $29,574,000 after buying an additional 541,728 shares during the last quarter. Millennium Management LLC grew its holdings in Select Medical by 183.9% during the second quarter. Millennium Management LLC now owns 679,522 shares of the health services provider’s stock worth $23,824,000 after acquiring an additional 440,140 shares during the period. Hood River Capital Management LLC purchased a new position in Select Medical during the second quarter valued at approximately $14,819,000. Finally, Ceredex Value Advisors LLC acquired a new position in Select Medical in the second quarter valued at approximately $11,456,000. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Stock Performance

Shares of NYSE:SEM opened at $37.01 on Wednesday. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. Select Medical Holdings Co. has a 1 year low of $22.26 and a 1 year high of $40.98. The firm has a market capitalization of $4.79 billion, a PE ratio of 17.29, a P/E/G ratio of 1.95 and a beta of 1.42. The business’s 50 day moving average price is $34.87 and its 200-day moving average price is $34.88.

Select Medical (NYSE:SEM) last released its earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The company’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.46 earnings per share. As a group, equities research analysts expect that Select Medical Holdings Co. will post 2.16 earnings per share for the current fiscal year.

Select Medical Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, November 26th. Shareholders of record on Wednesday, November 13th will be paid a $0.125 dividend. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.35%. The ex-dividend date is Wednesday, November 13th. Select Medical’s dividend payout ratio (DPR) is presently 23.36%.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on SEM. Bank of America began coverage on shares of Select Medical in a research note on Tuesday, August 20th. They issued a “buy” rating and a $42.00 target price for the company. Royal Bank of Canada increased their target price on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. StockNews.com upgraded Select Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 13th. Finally, Benchmark reissued a “buy” rating and issued a $48.00 price objective on shares of Select Medical in a report on Friday, November 1st. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $40.75.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.